Results 261 to 270 of about 1,818,147 (330)

Cardiovascular disease and adult healing cells: From bench top to bedside [PDF]

open access: yes, 2017
Black Jr., Asa C   +8 more
core   +1 more source

Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries

open access: yesArthritis &Rheumatology, EarlyView.
Objective Our objective was to assess the incidence of major adverse cardiovascular events (MACEs) in patients with rheumatoid arthritis (RA) treated with JAK inhibitors (JAKi), tumor necrosis factor inhibitors (TNFi), or biologic disease‐modifying antirheumatic drugs with other modes of action (bDMARD‐OMA) in a multicountry, real‐world population ...
Romain Aymon   +28 more
wiley   +1 more source

Early initiation of SGLT2 inhibitors after acute myocardial infarction. [PDF]

open access: yesEur Heart J Cardiovasc Pharmacother
Hammer A, Sossalla S, Sulzgruber P.
europepmc   +1 more source

ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.

open access: yesEuropean Heart Journal, 2016
S. Agewall   +13 more
semanticscholar   +1 more source

Fabrication of Polypyrrole–Polystyrene Sulfonate by Amperometric Biosensor‐Based Electropolymerization for Cholesterol Determination in Serum

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Since cholesterol triggers many diseases, many methods have been developed for its determination. In this study, an alternative system for cholesterol determination was developed by preparing amperometric biosensors. In the development of the biosensor, Pt/polypyrrole–polystyrene sulfonate film was prepared by electropolymerization of ...
Alaa Anwer Ali Dada   +3 more
wiley   +1 more source

Plant-derived hydrogel and photosynthetic nano-units for myocardial infarction therapy. [PDF]

open access: yesNat Commun
Lv Y   +11 more
europepmc   +1 more source

The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Several methods exist to identify hospital admissions related to adverse drug events (ADEs). Clinical adjudication by healthcare professionals is the gold standard but is labour‐intensive. Spontaneous reporting and routinely collected healthcare data using a set of International Classification of Diseases (ICD) codes often underestimate the ...
Zuzana Juhásová   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy